Number of pages: 100 | Report Format: PDF | Published date: February 20, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
According to the deep-dive market assessment study by Growth Plus Reports, the global lymphedema treatment market was valued at US$ 780 million in 2021 and is expected to register a revenue CAGR of 8.1% to reach US$ 1,572 million by 2030.
Lymphedema Treatment Market Fundamentals
The global lymphedema treatment market is expected to grow significantly in the next few years due to the increasing prevalence of the condition, advancements in treatment options, growing awareness of the condition, and the availability of a wide range of lymphedema treatment products and services. The market is driven by an aging population, a rising incidence of cancer, and an increase in surgical procedures, all of which can increase the risk of lymphedema. Compression garments are the most commonly used products for the management of lymphedema. However, other products, such as pumps and bandages, are also important. Surgical procedures and novel therapies, such as gene and stem cell therapy, are expected to contribute to market revenue growth. The market is highly fragmented, with many players offering a range of products and services.
The global lymphedema treatment market is expected to experience continued growth in the coming years, driven by increasing prevalence, advancements in treatment options, patient-centered care, and the availability of a wide range of lymphedema products and services.
Lymphedema is a chronic condition resulting from the accumulation of lymphatic fluid in the tissues, causing swelling in the affected body part. Lymphedema treatment may include a combination of approaches, such as compression therapy, manual lymphatic drainage, exercise, skincare, and surgery. The goal of lymphedema treatment is to improve the flow of lymphatic fluid, reduce swelling, and prevent infection and other complications associated with the condition. Treatment may be tailored to the individual needs of each patient. It may involve ongoing management to help control the symptoms of the condition.
Lymphedema Treatment Market Dynamics
The incidence of lymphedema is growing worldwide due to an aging population, rising incidence of cancer, and an increase in the number of surgical procedures. Significant advancements in the development of new compression garments, surgical procedures, and novel therapies, such as gene therapy and stem cell therapy, are expected to improve treatment outcomes and expand the range of options available to patients. Governments around the world are taking initiatives to increase awareness about lymphedema and provide better treatment options to patients. For instance, the U.S. introduced the Lymphedema Treatment Act of 2022 to improve access to treatment for lymphedema patients, which is promoting the growth of the lymphedema treatment market in the country.
The growing availability of lymphedema products and accessories is also expected to contribute to market revenue growth. As healthcare expenditure continues to rise globally, patients can access better treatment options for lymphedema. This is expected to drive the growth of the lymphedema treatment market in the coming years.
However, the high cost associated with lymphedema treatment, especially for patients who require ongoing therapy or surgical interventions, is the major restricting factor of the global lymphedema treatment market. Moreover, in some countries, there are no or limited reimbursement policies for lymphedema treatment, which is cramping the revenue growth of the lymphedema treatment market.
Lymphedema Treatment Market Ecosystem
The global lymphedema treatment market is analyzed from three perspectives: indication, treatment type, end-user, and region.
Lymphedema Treatment Market by Indication
Based on the indication, the global lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema.
The secondary lymphedema segment dominated the lymphedema treatment market with the highest revenue share in 2021. Secondary lymphedema has a higher incidence rate than primary lymphedema, as it can occur in people of all ages and can be caused by various factors. This leads to a larger patient population needing treatment, boosting segment revenue growth. There is greater awareness about the risk of developing lymphedema after cancer surgery, which means patients are more likely to seek treatment for secondary lymphedema. Moreover, more treatment options are available for secondary lymphedema, including compression therapy, manual lymphatic drainage, and surgery, thus propelling segment growth. In some countries, reimbursement policies may cover treatment for secondary lymphedema, making it more accessible to patients. This can further drive demand for lymphedema treatment options.
Lymphedema Treatment Market by Treatment Type
Based on the treatment type, the global lymphedema treatment market is segmented into compression therapy, drug therapy, laser therapy, and others.
The compression therapy segment accounted for the largest revenue share of the lymphedema treatment market in 2021. Compression therapy has been shown to effectively reduce swelling and improve lymphatic flow in patients with lymphedema. It is often recommended as the first-line treatment for lymphedema and is considered a standard of care for the condition, thus increasing the demand for compression therapy in lymphedema treatment. Compression therapy is a non-invasive treatment that does not require surgery or medication. This makes it an attractive option for patients who prefer non-invasive treatments or cannot undergo surgery. The therapy is relatively cost-effective compared to other lymphedema treatments, such as surgery or manual lymphatic drainage. It is also a long-term treatment option, and compression garments can be reused and washed multiple times, thus propelling the segment’s growth.
Lymphedema Treatment Market by End-user
Based on the end-user, the global lymphedema treatment market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others.
The hospitals segment accounted for a significant revenue share of the lymphedema treatment market in 2021. Hospitals typically have specialized departments and healthcare professionals trained in the management of lymphedema, such as surgeons, physical therapists, and occupational therapists. This makes hospitals a preferred choice for patients seeking advanced care and treatment for lymphedema. Hospitals have access to a wider range of treatment options for lymphedema, including advanced surgical procedures, medical devices, and therapeutic interventions, which is propelling segmental growth. Hospitals can perform a wide range of diagnostic tests and imaging procedures to diagnose and evaluate lymphedema. This can help develop an effective treatment plan for the patient, thus boosting segmental growth.
Lymphedema Treatment Market by Region
Geographically, the global lymphedema treatment market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominated the global lymphedema treatment market in 2021 due to the relatively high prevalence of lymphedema, which drives demand for treatment options. According to the National Center for Biotechnology Information, primary lymphedema affects around 1 in 100,000 individuals, and secondary lymphedema affects approximately 1 in 1000 in the U.S. There has been a growing interest in new and innovative treatment options for lymphedema in North America, such as pneumatic compression devices, lymphaticovenous anastomosis (LVA) surgery, and liposuction. North America is home to some of the most advanced medical technologies in the world, including medical devices and surgical procedures that can be used to treat lymphedema. This has driven the development of innovative treatment options for lymphedema. Moreover, there is increasing awareness about lymphedema in the region, which has led to greater patient education and more effective diagnosis and treatment, boosting market revenue growth in the region. The aging population in North America is at a higher risk for developing lymphedema, as age-related changes in the lymphatic system can increase the likelihood of the condition.
Lymphedema Treatment Market Competitive Landscape
The prominent players operating in the global lymphedema treatment market are:
Lymphedema Treatment Market Strategic Developments
Geographically, North America has the largest market revenue share, followed by Europe; and Asia Pacific is the fastest-growing regional market for lymphedema treatment.
Lymphedema treatment refers to the various interventions and approaches used to manage and alleviate the symptoms of lymphedema. This chronic condition results from the accumulation of lymphatic fluid in the tissues, causing swelling in the affected body part.
Bio Compression Systems Inc., AIROS Medical Inc., Tactile Systems Technology Inc, Smith & Nephew plc, and BSN Medical GmbH are among the top players operating in the global lymphedema treatment market.
The compression therapy segment accounts for the largest revenue share of the lymphedema treatment market.
The lymphedema treatment market is estimated to be valued at US$ 1,572 million by 2030.
*Insights on financial performance are subject to the availability of information in the public domain